Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results
'Our second quarter results reflect broad-based, consistent execution across the business,' said Robert Spignesi, President and CEO. 'Total revenue increased 10%, driven by an 18% increase in Service revenue. Product revenue increased by 6%, led by mid-teens growth in consumables. With continued strong customer interest in Growth Direct and meaningful progress across our broader business, we are reiterating our full-year 2025 revenue guidance.'
'In addition, this morning we announced a new five-year, $45 million term loan facility, with $20 million funded upfront with highly favorable terms, including no financial or liquidity covenants,' continued Spignesi. 'This facility significantly strengthens our financial position and reinforces our ability to achieve positive cash flow. Our strategic priorities remain unchanged, and this capital supports our continued focus on delivering significant long-term revenue growth, gross margin expansion and shareholder value.'
Second Quarter Financial Results
Total revenue for the second quarter of 2025 increased 10% to $7.3 million compared to $6.6 million in the second quarter of 2024. The Company placed four new Growth Direct® systems and completed the validation of two customer systems compared to five placements and five validations in the second quarter of 2024. Product revenue increased by 6% to $4.8 million, compared to $4.5 million in the second quarter of 2024. Service revenue increased by 18% to $2.5 million, compared to $2.1 million in the second quarter of 2024. Recurring revenue increased by 15% to $4.4 million, compared to $3.8 million in the second quarter of 2024.
Total cost of revenue was $7.0 million in the second quarter of 2025, an increase of 3% compared to $6.8 million in the second quarter of 2024. Gross margin was positive 4%, or positive $0.3 million, compared to negative 3%, or negative $0.2 million in the second quarter of 2024.
Total operating expenses decreased by 6% to $12.4 million in the second quarter of 2025, compared to $13.2 million in the second quarter of 2024. General and administrative expenses increased 4%, research and development expenses decreased by 14%, and sales and marketing expenses decreased by 14%, in each case compared to the second quarter of 2024.
Net loss for the second quarter of 2025 was $11.9 million, compared to $12.6 million in the second quarter of 2024. Net loss per share for the second quarter of 2025 was $0.27, compared to $0.29 in the second quarter of 2024.
Cash, cash equivalents, short-term investments, and restricted cash were approximately $32 million as of June 30, 2025.
2025 Outlook
The Company is reaffirming its full year 2025 total revenue guidance of at least $32.0 million.
Loan Facility
In a separate release issued today, the Company announced that it has entered into a five-year, $45 million term loan facility with Trinity Capital Inc. The Company received $20 million at close through the first tranche and has access to two additional tranches totaling $20 million, subject to the achievement of certain commercial and operational milestones. A fourth tranche of $5 million is available at the lender's discretion.
For additional details regarding this facility, please refer to the related press release at https://investors.rapidmicrobio.com/news-and-events/news-releases.
Webcast Details
The Company will host a conference call before the market opens today, August 12, 2025, at 8:30 a.m. ET to discuss its second quarter 2025 financial results. The live call is accessible on the Company's website at investors.rapidmicrobio.com and will be archived and available for replay for one year.
About Rapid Micro Biosystems
Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control ('MQC') testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct system brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered in Lexington, Massachusetts and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands. For more information, please visit www.rapidmicrobio.com or follow the Company on X (formerly known as Twitter) at @rapidmicrobio or on LinkedIn.
Rapid Micro Biosystems intends to use the Investor Relations page of its website as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor its website in addition to following press releases, filings with the Securities and Exchange Commission ('SEC'), public conference calls, presentations and webcasts.
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding the Company's guidance, including with respect to full year 2025 total revenue and number of Growth Direct placements; the Company's goal of achieving cash flow breakeven; the Company's newly-announced debt facility; the Company's ability to reduce product costs, and improve manufacturing efficiency and service productivity; and the Company's ability to advance its priorities of accelerating Growth Direct system placements, improving gross margins and innovating new products.
In some cases, you can identify forward-looking statements by terminology such as 'outlook,' 'aim,' 'anticipate,' 'assume,' 'believe,' 'contemplate,' 'continue,' 'could,' 'due,' 'estimate,' 'expect,' 'goal,' 'intend,' 'may,' 'objective,' 'plan,' 'predict,' 'potential,' 'positioned,' 'seek,' 'should,' 'target,' 'will,' 'would' and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements involve known and unknown risks, uncertainties and assumptions which may cause actual results to differ materially from any results expressed or implied by any forward-looking statement, including, but not limited to risks related to, the Company's ability to achieve positive cash flow; the Company's ability to achieve its business objectives; the Company's significant losses since inception; the Company's ability to meet its publicly announced guidance and other expectations about its business and operations; the impact of the Company's existing and any future indebtedness on its ability to operate its business; the Company's ability to access any future tranches under its debt facility and to comply with all of its obligations thereunder, the Company's limited experience in marketing and sales and the effectiveness of its sales processes; the Company's need to develop new products and adapt to technological changes; the Company's ability to establish and maintain its position as a leading provider of automated microbial quality control testing; the Company's ability to maintain its manufacturing facility; the Company's ability to improve the gross margins of its products and services; risks related to third-parties; the Company's ability to retain key management and other employees; risks related to regulatory and intellectual property matters; risks related to supply chain disruptions and the impact of inflation; risks associated with macroeconomic events and uncertainty, including with respect to tariff and trade policy in the U.S. and abroad, as well as activity in the Company's industry and in the general economy; and the other important factors outlined under the caption 'Risk Factors' in the Company's Quarterly Report on Form 10-Q filed with the SEC, as such factors may be updated from time to time in its other filings with the SEC, which are available on the SEC's website at www.sec.gov and the Investor Relations page of its website at investors.rapidmicrobio.com. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it cannot guarantee future results. The Company has no obligation, and does not undertake any obligation, to update or revise any forward-looking statement made in this press release to reflect changes since the date of this press release, except as may be required by law.
Investor Contact Michael Beaulieu, CFA Vice President, Investor Relations and Corporate Communications [email protected] Media Contact [email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Poll: Ramaswamy, Acton in dead heat for 2026 governor's race
Aug. 12—A new poll shows the 2026 Ohio governor's race is tight at this early stage. According to a new survey from Impact Research Republican Vivek Ramaswamy leads Democrat Amy Acton, 47-46 percent, with 7 percent undecided. Ramaswamy, a businessman who ran in the 2024 presidential election currently leads for his party's nomination, with his opponent Ohio Attorney General David Yost withdrawn from the race. He faces entrepreneur Heather Hill in the Republican primary. Trending * Westbound ramp of U.S. 52 to State Route 141 will be closed starting Monday * Two Hearts opens Ironton location Acton, who served as the state's health director during the 2020 beginning of the COVID-19 pandemic, is the only announced Democrat seeking the governorship. While Ohio has voted straight Republican in all statewide races the past few elections, the race appear competitive, due to the candidates' favorability scores. The survey found that Acton has a 60 percent recognition of name ID among voters and is viewed positively by 33 percent of voters and negatively by 28 percent. Ramaswamy is known by 80 percent of voters and is viewed positively by 44 percent, with 41 percent having a negative view. The poll of 800 likely voters was conducted from July 24-28 and has a margin of error of +/- 3.5 percent. Impact Research is a Democratic polling and strategy firm. The results of their survey are slightly closer than a Bowling Green State University poll, taken in April, which had Ramaswamy leading 50-45 percent. Trending * Studio Dara grand reopening set for Sept. 5 * Citizenship Awards presented You Might Like News Westbound ramp of U.S. 52 to State Route 141 will be closed starting Monday Business Two Hearts opens Ironton location Business Studio Dara grand reopening set for Sept. 5 News Citizenship Awards presented Solve the daily Crossword
Yahoo
12 minutes ago
- Yahoo
StubHub is once again working on its IPO that could raise $1B
StubHub is giving a strong indication that its IPO is back on again. It filed a public S-1 in late March, then paused in April after the Trump administration's tariffs spooked Wall Street. On Monday, it filed an updated S-1 that now includes Q1 2025 experts Renaissance Capital estimated in March that the IPO could raise $1 billion, and says this fresh S-1 could mean a debut next month. StubHub declined to comment on its IPO plans, citing its quiet period. In 2024, it generated nearly $1.8 billion in revenue and recorded a net loss of $2.8 million. Its biggest shareholder is Madrone Partners (27.1%) followed by WestCap Management (10.8%) and Bessemer (9.6%). Founder CEO Eric Baker holds only 5.2% of the Class A shares, but he holds all of the super-voting rights Class B shares (4.95 million), which puts him in control with 90% of the vote. Sign in to access your portfolio
Yahoo
12 minutes ago
- Yahoo
CuriosityStream Announces Secondary Public Offering of Shares of Common Stock
SILVER SPRING, Md., August 12, 2025--(BUSINESS WIRE)--CuriosityStream, Inc. (the "Company") (Nasdaq: CURI), a leading global factual media company, has announced today the launch of an underwritten secondary offering by a selling stockholder of shares of the Company's common stock, par value of $0.0001 ("Common Stock"). The offering includes an option for the underwriters to purchase up to an additional 15% of the shares of common stock offered in the offering within 30 days at the public offering price, less underwriting discounts and commissions. Needham & Company and Craig-Hallum will serve as joint book-running managers for the offering. The selling stockholder will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering. The offering is being conducted through a shelf registration statement on Form S-3 that was declared effective on May 3, 2022. Before you invest, you should read the prospectus supplement and accompanying prospectus forming a part of that registration statement and other documents the Company has filed with the Securities and Exchange Commission ("SEC") for more complete information about the Company and the offering. Copies of the preliminary prospectus supplement and accompanying prospectus relating to the offering, once available, may be obtained for free on the SEC's website at or from Needham & Company, LLC, 250 Park Avenue, 10th Floor, New York, NY 10177, Attn: Prospectus Department, prospectus@ or by telephone at (800) 903-3268 or from Craig-Hallum Capital Group LLC, Attention: Equity Capital Markets, 222 South Ninth Street, Suite 350, Minneapolis, MN 55402, by telephone at (612) 334-6300 or by email at prospectus@ This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Cautionary Statements Regarding Forward-Looking Information Certain statements in this press release may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 including, but not limited to, including statements regarding the size, terms and use of proceeds of the offering. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events or results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words "believes," "estimates," "expects," "projects," "forecasts," "may," "will," "should," "seeks," "plans," "scheduled," "anticipates," "predicts" or "intends" or similar expressions. Such forward-looking statements involve risks and uncertainties that may cause actual events, results or performance to differ materially from those indicated by such statements. Certain of these risks are identified and discussed under "Risk Factors" in CuriosityStream's Annual Report on Form 10-K for the year ended December 31, 2024, that we filed with the Securities and Exchange Commission (the "SEC") on March 25, 2025, and in CuriosityStream's other SEC filings. These risk factors are important to consider in determining future results and should be reviewed in their entirety. Forward-looking statements are based on the current belief of the management of CuriosityStream, based on currently available information, as to the outcome and timing of future events, and involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements. However, there can be no assurance that the events, results or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made, and CuriosityStream is not under any obligation, and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Readers should carefully review the statements set forth in the reports that CuriosityStream has filed or will file from time to time with the SEC. In addition to factors previously disclosed in CuriosityStream's reports filed with the SEC and those identified elsewhere in this communication, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance: (i) risks related to CuriosityStream's ability to maintain and develop new and existing revenue-generating relationships and partnerships or to significantly increase CuriosityStream's subscriber base and retain customers; (ii) the effects of pending and future legislation; (iii) risks of the internet, online commerce and media industry; (iv) the highly competitive nature of the internet, online commerce and media industry and CuriosityStream's ability to compete therein; (v) litigation, complaints, and/or adverse publicity; (vi) privacy and data protection laws, privacy or data breaches, or the loss of data, and (vii) the ability to license content for purposes of training generative artificial intelligence models. Readers should carefully review the statements set forth in the reports that CuriosityStream has filed or will file from time to time with the SEC. About CuriosityStream Inc. CuriosityStream Inc. is the entertainment brand for people who want to know more. The global media company is home to award-winning original and curated factual films, shows, and series covering science, nature, history, technology, society, and lifestyle. With millions of subscribers worldwide and thousands of titles, the company operates the flagship Curiosity Stream SVOD service, available in more than 175 countries worldwide; Curiosity Channel, the linear television channel available via global distribution partners; Curiosity University, featuring talks from the best professors at the world's most renowned universities as well as courses, short and long-form videos, and podcasts; Curiosity Now, Curiosity Explora, and other free, ad-supported channels; Curiosity Audio Network, with original content and podcasts; and Curiosity Studios, which oversees original programming. Curiosity Inc. is a wholly owned subsidiary of CuriosityStream Inc. (Nasdaq: CURI). View source version on Contacts CuriosityStream Investor Relations Brett Maas IR@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
